Endovascular Treatment of Peripheral Artery Disease (PAD)

Inclusion criteria

• Patient must sign the informed consent form prior to the index-procedure.
• Patient is older than 18 years.
• Patient is compliant with the requested follow-up visits at week 6 and month 12 and the treatment regime.
• Patient suffers from mild to intermittent claudication (Rutherford 1-3) or critical limb ischemia (Rutherford 4-5).
• Target lesion is an occlusion or diameter stenosis is ≥50% by visual estimate.
• Target lesion is located in the common and external iliac artery, in the common and superficial femoral artery, popliteal artery and/or the below-the-knee (BTK) arteries (anterior tibial artery, posterior tibial artery or peroneal artery).

Exclusion criteria

• Patients with Rutherford 0 and 6.
• Patient is pregnant.
• Patients with estimated Glomerular filtration rate (eGFR) < 30 mL/min/1.73m2.
• Patient has an acute thrombus or aneurysm in the target arteries.
• Patient has a life expectancy of <12 months.
• Patient has a target lesion that cannot be crossed with a guidewire.
• Patient suffers from acute limb ischemia defined as any sudden decrease in limb perfusion causing a potential threat to limb viability.
• Patient has scheduled elective non-vascular procedures within 3 months after index-procedure. Vascular procedures are allowed within 3 months after the index-procedure if it is guaranteed that acetylic salicylic acid and clopidogrel intake is not interrupted.
• Contraindication for anti-thrombotic therapy (coagulopathy, …).
• Patient has a known intolerance to anti-thrombotic medication or contrast agents.